MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 12-27-2025
Autolus Therapeutics plc P/E Ratio 2011-2025 | AUTL
Annual P/E Ratio Autolus Therapeutics plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.92 | -5.22 | -2.01 | -1.9 | -2.34 | -2.84 | -52.1 | -2.2 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.9 | -52.1 | -8.82 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptevo Therapeutics
APVO
|
-0.0368 | $ 0.61 | - | $ 168 K |  USA |
 |
Aclaris Therapeutics
ACRS
|
-1.15 | $ 3.03 | -0.33 % | $ 234 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.12 | 0.81 % | $ 7.51 B |  Australia |
 |
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
-0.958 | $ 1.14 | - | $ 6.22 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | USA |
 |
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | USA |
 |
BioVie
BIVI
|
-0.139 | $ 1.21 | - | $ 1.79 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-19.2 | $ 208.98 | -1.8 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - |  Russia |
 |
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 0.21 | 1.13 % | $ 457 M |  Israel |
 |
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.333 | - | -9.72 % | $ 5.89 M | USA |
 |
Catalyst Biosciences
CBIO
|
-0.393 | $ 12.35 | -0.16 % | $ 813 M | USA |
 |
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
6.11 | $ 94.52 | -0.54 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
8.2 | $ 27.12 | - | $ 1.31 B | USA |
 |
Certara
CERT
|
-165 | $ 8.89 | - | $ 1.43 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
-8.34 | - | -10.95 % | $ 876 K | USA |
 |
Anika Therapeutics
ANIK
|
-4.51 | $ 9.55 | - | $ 140 M | USA |
 |
bluebird bio
BLUE
|
-0.316 | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
106 | $ 583.84 | - | $ 44.2 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-1.16 | $ 2.45 | -3.16 % | $ 15.4 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
46.4 | $ 82.65 | -1.12 % | $ 8.53 B | USA |
 |
AstraZeneca PLC
AZN
|
706 | $ 92.9 | - | $ 96.9 B | Britain |
 |
ChromaDex Corporation
CDXC
|
50.4 | - | -0.88 % | $ 598 M | USA |
 |
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
12.2 | $ 9.09 | 1.0 % | $ 1.47 B | Britain |
 |
CorMedix
CRMD
|
-3.76 | $ 12.53 | - | $ 638 M | USA |